These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31426735)

  • 1. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2017.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2019 Aug; 43():. PubMed ID: 31426735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2018.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019.
    Bell JM; Lubian AF; Partridge S; Gottlieb T; Iredell J; Daley DA; Coombs GA
    Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014.
    Bell JM; Turnidge JD; Coombs GW; Daley DA; Gottlieb T; Robson J; George N
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E229-35. PubMed ID: 27522134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020.
    Bell JM; Lubian AF; Partridge SR; Gottlieb T; Iredell J; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2022 Mar; 46():. PubMed ID: 35382709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2022.
    Bell JM; Fajardo Lubian A; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015.
    Bell JM; Gottlieb T; Daley DA; Coombs GW;
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP).
    Bell JM; Lubian AF; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2022 Nov; 46():. PubMed ID: 36384435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.
    Coombs GW; Daley DA; Lee YT; Pang S; Bell JM; Turnidge JD;
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-onset Gram-negative Surveillance Program annual report, 2011.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Pearson JC; Bell JM;
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E49-53. PubMed ID: 25409355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Pearson JC; Bell JM;
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E219-23. PubMed ID: 24890957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-onset Gram-negative Surveillance Program annual report, 2012.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E54-8. PubMed ID: 25409356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance in gram-negative bacilli: a Singapore perspective.
    Tan TY; Hsu LY; Koh TH; Ng LS; Tee NW; Krishnan P; Lin RT; Jureen R
    Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
    Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
    Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
    Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.